VAREX IMAGING Reports Q3 FY2023 Earnings Results for June 30 2023

August 7, 2023

🌥️Earnings Overview

On August 1, 2023, VAREX IMAGING ($NASDAQ:VREX) revealed their financial results for the third quarter of the fiscal year 2023, which ended on June 30, 2023. Total revenue for the quarter was USD 232.2 million, a growth of 8.3% compared to the same period last year. Additionally, net income also rose 11.0% year over year to USD 9.1 million.

Market Price

VAREX IMAGING has reported its earnings results for the period ending June 30 2023, the third quarter of fiscal year 2023. On Tuesday, VAREX IMAGING stock opened at $23.2 and closed at $23.0, which is a 1.2% decrease from the prior closing price of 23.3. Despite this minor dip in share price, the company has reported an overall increase in revenues and profits for the period. The report includes a detailed analysis of the company’s performance in terms of sales and profitability. It also highlights key factors that may have influenced the company’s performance such as market trends, changes in regulatory environment, and competitive pressures.

In addition, the report also provides insights on the outlook for VAREX IMAGING moving forward, and potential strategies for ensuring sustained growth and profitability. Overall, despite the slight drop in share price, VAREX IMAGING has reported positive results for the third quarter of fiscal year 2023. The company continues to be well positioned to capitalize on opportunities as they arise, and continues to remain an attractive investment option for investors. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Varex Imaging. More…

    Total Revenues Net Income Net Margin
    897.4 29.4 3.4%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Varex Imaging. More…

    Operations Investing Financing
    78.4 -57.8 -1.4
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Varex Imaging. More…

    Total Assets Total Liabilities Book Value Per Share
    1.21k 666.8 13.16
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Varex Imaging are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    5.2% 20.4% 8.2%
    FCF Margin ROE ROA
    5.9% 8.7% 3.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    Our Risk Rating based on both financial and business aspects gives VAREX IMAGING a high risk rating. Upon further analysis, we have detected two risk warnings in their balance sheet. For more information, you can register with us and check it out. We can help you make an informed decision about investing in VAREX IMAGING. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The competition between Varex Imaging Corp and its competitors is intense. The company must continually innovate and improve its products and services to stay ahead of the competition. It must also provide value to its customers through its pricing and customer service.

    – Integer Holdings Corp ($NYSE:ITGR)

    Valero Energy Corporation is an independent petroleum refining and marketing company with operations in the United States, Canada, the United Kingdom, Ireland, and Jamaica. Valero is the world’s largest independent petroleum refiner and marketer and the largest ethanol producer in the United States. The company owns 15 petroleum refineries with a combined throughput capacity of approximately 3 million barrels per day. Valero also owns 10 ethanol plants with a combined production capacity of approximately 1.4 billion gallons per year.

    – Precision Optics Corp Inc ($OTCPK:PEYE)

    Precision Optics Corporation, Inc. engages in the design, manufacture, and integration of optical products and solutions. The company offers its products and services to the medical, scientific, industrial, commercial, and military markets in the United States and internationally. It operates in two segments, Medical Devices and Commercial/Industrial. The Medical Devices segment provides medical products, including fiber optic delivery systems for lasers used in minimally invasive surgery, as well as endoscopic equipment that allow physicians to see inside the human body without making large incisions; medical laser handpieces that are used in a number of minimally invasive surgical procedures; and medical diagnostic equipment. This segment also manufactures intraocular lens products for the eye care market. The Commercial/Industrial segment provides optical products for use in a variety of applications, including video projection, machine vision, aerospace and defense, automotive head-up displays, and others. Precision Optics Corporation, Inc. was founded in 1985 and is headquartered in Westford, Massachusetts.

    – Diagnostic Medical Systems SA ($LTS:0RIA)

    The company’s market cap is 16.12M as of 2022. The company’s ROE is -18.05%. The company’s market cap and ROE are both down from the previous year. The company’s market cap is down because the company’s revenue and net income are both down. The company’s ROE is down because the company’s net income is down. The company’s market cap and ROE are both down because the company’s stock price is down. The company’s market cap is down because the company’s earnings per share are down.

    The company is a medical device company that manufactures and sells diagnostic and therapeutic products. The company’s products are used in the diagnosis and treatment of diseases and disorders of the human body. The company’s products are sold to hospitals, clinics, and other healthcare facilities around the world.


    VAREX IMAGING reported a solid quarter ending June 30, 2023, with total revenue of USD 232.2 million, an 8.3% increase from the previous year. Net income was up 11.0% year over year, standing at USD 9.1 million. This indicates that the company is continuing to perform well and may be a good investment opportunity. Investors should consider VAREX IMAGING’s strong balance sheet and consistent earnings growth as potential upside for the stock price.

    Additionally, investors should watch for any potential catalysts that can drive further growth, such as expansion into new markets and product launches.

    Recent Posts

    Leave a Comment